[#item_full_content] … [Read more...] about Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters’ Option to Purchase Additional Shares
biotech news
Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting
MDxHealth annonce une proposition de transition vers une cotation unique de ses actions sur le Nasdaq et convoque une assemblée générale extraordinaire des actionnaires
Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
[#item_full_content] … [Read more...] about Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
You must be logged in to post a comment.